In a new study first reported by TrialSite News, approximately 27% of participants surveyed in Saudi Arabia experienced heart complications following mRNA COVID-19 inoculation.
The onset of heart issues ranged from within one month to more than a year later.
“While the authors of this study seem to downplay the magnitude of the response, TrialSite cannot ignore what appears as a staggering number of cardiovascular complications self-reported post COVID-19 vaccination. 27.11% of the total sample found themselves in the hospital with some form of cardiac complication after receiving a mRNA COVID-19 vaccine,” TrialSite News wrote.
“Of course, this study isn’t designed to prove that the vaccines were the cause, but the associations are statistically significant and cannot be ignored. Comorbidities are likely a factor,” the outlet added.
Bombshell Saudi Arabian Study: 27.11% of Study Population Report Cardiac Complications Post COVID-19 mRNA Vaccination https://t.co/03W3ur0mw0
— TrialSite News (@TrialsiteN) April 3, 2024
From TrialSite News:
Conducting the cross-sectional design-based study, the team of investigators used culturally adapted questionnaires covering demographic details, vaccination history, health conditions, and perceptions. The study on self-reported physician-diagnosed cardiac complications post mRNA vaccination in Saudi Arabia represents a pivotal contribution to the ongoing global efforts to understand the safety profile of mRNA-based vaccines. Overall, a strong study in regard to methodology, relevance, and ethical considerations contribute what Sheriff and colleagues point out as “valuable insights into the safety profile of mRNA vaccines in the specific context, fostering informed public health strategies in Saudi Arabia.”
“The onset of cardiac complications varied, with 14.55% experiencing symptoms within one month of vaccination + others reporting issues up to 12 months or longer,” Children's Health Defense noted.
🚨 ‘Bombshell’ Study: 27% of mRNA-Vaccinated Saudis Suffered Heart Complications
The onset of cardiac complications varied, with 14.55% experiencing symptoms within one month of vaccination + others reporting issues up to 12 months or longer.
— Children’s Health Defense (@ChildrensHD) April 5, 2024
Cardiologist Dr. Peter A. McCullough “said that in addition to the large number of cardiovascular symptoms warranting hospitalization, 15.8% landed in an intensive care unit (ICU),” The Defender reports.
“More than half of subjects indicated they were influenced by a healthcare professional or government agency to get vaccinated,” McCullough told the outlet.
“Never in recent times has there been such a cardiotoxic vaccine released on the public,” he added.
A study in Saudi Arabia found that over a quarter of participants experienced heart complications after receiving an mRNA COVID-19 vaccine. https://t.co/G6m5Ur0dyp
— Together In Truth (@togetherintruth) April 5, 2024
The Defender reports:
The Saudi Arabian study, published in the medical journal Cureus, employed a cross-sectional design and recruited 804 participants (379 men, 425 women, ages 18 and above) who had received at least one dose of an mRNA COVID-19 vaccine (Pfizer-BioNTech, Moderna or both — 58 took a different brand).
Nearly 40% took just one shot.
Participants completed a culturally adapted questionnaire covering demographic details, vaccination history, health conditions and perceptions related to the vaccines.
The onset of cardiac complications for the 27.11% of affected participants varied, with 14.55% occurring within one month of vaccination, 6.97% between one and three months, and others experiencing issues up to 12 months or more after receiving the vaccine.
For the 15.8% admitted to critical care units and 11.44% to general hospital wards, inpatient treatment lasted from less than one day to several weeks, with 8.33% spending between four and seven days in the hospital.
Treatment for cardiac complications was ongoing for many participants, with 9.45% receiving medical care for more than 12 months and 7.11% undergoing continuous treatment at the time of the survey.
Sixty-five percent of subjects reported being “neutral,” “somewhat not confident” or “not confident at all” on the safety of mRNA vaccines, while only about 20% said they believed their cardiac symptoms were “strongly related” or “somewhat related” to the vaccines.
The study also found high rates of pre-existing health conditions among the participants, including diabetes (48.26%), hypertension (56.72%), obesity (39.15%) and sedentary lifestyle-related issues (22.14%).
These comorbidities may have contributed to the increased risk of cardiac complications following mRNA vaccination, according to the study authors.
Read the full study HERE.
Source link